"ER negative tumors" trang 1 - tải miễn phí từ tailieunhanh
Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology

Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology
13    62    1
The prevalence of estrogen receptor-negative breast cancer in Ethiopia

The prevalence of estrogen receptor-negative breast cancer in Ethiopia
6    28    1
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
16    44    1
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status
11    50    1
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    90    0
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion

Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion
14    43    1
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis

The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
14    35    1
Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study

Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study
12    64    1
Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial
12    43    1
Relationship between tumor microbiota transcriptional activity and gene expression in breast cancer

Relationship between tumor microbiota transcriptional activity and gene expression in breast cancer
10    2    1
Examestane in advanced or recurrent endometrial carcinoma: A prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Examestane in advanced or recurrent endometrial carcinoma: A prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
7    37    1